Baylor Genetics
Liming Luo is a Clinical Tech Transfer Scientist at Baylor Genetics since April 2023, focusing on NGS assay optimization and clinical data review. Previously, Liming served as a Technical Account Manager at GenScript from August 2022 to November 2022, providing scientific consultation and managing projects in gene synthesis, peptide synthesis, and CRISPR gRNA design. Liming worked as an Instructor at Baylor College of Medicine from June 2012 to July 2022, collaborating with Biogen Inc. on an RNA-based gene regulation system for gene therapy. Additionally, Liming was a Postdoctoral Research Associate at Texas Tech University Health Sciences Center from November 2010 to December 2011, studying a hypothetical protein that regulates iron-related genes in Pseudomonas aeruginosa. Liming holds a Ph.D. in Molecular Biology and a Master of Science in Statistics, both from The University of Texas at Austin.
Baylor Genetics
Baylor Genetics is a joint venture of H.U. Group Holdings, Inc. and Baylor College of Medicine, including the #1 NIH-funded Department of Molecular and Human Genetics. Located in Houston’s Texas Medical Center, Baylor Genetics serves clients in 50 states and 16 countries.